Catalyst Pharmaceuticals
CPRX
#3529
Rank
โ‚ฌ3.51 B
Marketcap
28,71ย โ‚ฌ
Share price
0.00%
Change (1 day)
63.19%
Change (1 year)

Catalyst Pharmaceuticals (CPRX) - Total debt

Total debt on the balance sheet as of March 2026 : โ‚ฌ2.44 Million

According to Catalyst Pharmaceuticals's latest financial reports the company's total debt is โ‚ฌ2.44 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Catalyst Pharmaceuticals - Total debt on balance sheet (from 2018 to 2026)

Total debt by year

Year Total debt Change
2025-12-31โ‚ฌ2.37 M-22.56%
2024-12-31โ‚ฌ3.06 M-4.79%
2023-12-31โ‚ฌ3.21 M-11.36%
2022-12-31โ‚ฌ3.63 M-2.16%
2021-12-31โ‚ฌ3.71 M15636.94%
2020-12-31โ‚ฌ0.02 M-97.21%
2019-12-31โ‚ฌ0.84 M
2018-12-31N/A

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ40.70 B 1,665,360.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ57.60 B 2,357,005.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚ฌ31.03 B 1,269,836.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
โ‚ฌ0.95 B 38,909.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
โ‚ฌ0.17 B 7,207.72%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚ฌ3.83 B 156,640.02%๐Ÿ‡บ๐Ÿ‡ธ USA